GLAXF - GlaxoSmithKline plc (GSK) Management Presents at UBS Global Healthcare Conference (Transcript)

GlaxoSmithKline plc (GSK) UBS Global Healthcare Conference Call May 24, 2022 09:15 ET Company Participants Kimberly Smith - Head of Global Research & Medical Strategy Conference Call Participants Laura Sutcliffe - UBS Presentation Laura Sutcliffe All right. Good morning, everyone. Welcome back to day two of the UBS Global Healthcare Conference. My name is Laura Sutcliffe, I am a pharmaceuticals analyst here at UBS. And it's my great pleasure to have with me this morning, Dr. Kimberly Smith, who is the Head of R&D at ViiV Healthcare which most of you will know is GSK's HIV business, although, of course, it's a JV with Pfizer and Shionogi. So Kim, welcome. It would be great if you could start just by talking -- just introducing yourself and talking a little bit about kind of where you're leading the HIV business at GSK at the moment and then we'll get stuck into

For further details see:

GlaxoSmithKline plc (GSK) Management Presents at UBS Global Healthcare Conference (Transcript)